Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 14 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Nashik

← All India trials

Every active and recruiting clinical study with an investigative site in India — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

0

Recruiting now

8

Active studies

Starting soon Phase 4

A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Unresectable or Metastatic Melanoma Participants In India

Unresectable Melanoma, Metastatic Melanoma
Bristol-Myers Squibb · started 2026-11-15

📍 Nashik · Mumbai · Navi Mumbai · Pune · Bhubaneswar · Chennai

NCT07459543 on ClinicalTrials.gov ↗

Starting soon Phase 3

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2
Eli Lilly and Company · started 2026-09

📍 Ahmedabad · Aligarh · Bhubaneswar · Guntur · Mumbai · Nashik

NCT07668336 on ClinicalTrials.gov ↗

Starting soon Phase 3

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Type 2 Diabetes
Boehringer Ingelheim · started 2026-08-24

📍 Ahmedabad · Bhubaneswar · Hyderabad, Afzalgunj · Nagpur · Nashik · New Delhi

NCT07754461 on ClinicalTrials.gov ↗

Active Phase 2

A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

Advanced or Metastatic Breast Cancer
Pfizer · started 2024-01-09

📍 Surat · Bangalore · Mumbai · Nagpur · Nashik · Pune

NCT06105632 on ClinicalTrials.gov ↗

Active Phase 3

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis
Novartis Pharmaceuticals · started 2021-12-16

📍 Mangalore · Mumbai · Nashik · New Delhi · Chandigarh · Ludhiana

NCT05147220 on ClinicalTrials.gov ↗

Active Phase 3

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

Breast Neoplasms, Breast Cancer, HER2-positive Early Breast Cancer
AstraZeneca · started 2021-10-25

📍 Gurgaon · Howrah · Nagpur · Nashik · New Delhi · Raipur

NCT05113251 on ClinicalTrials.gov ↗

Active Phase 3

A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC · started 2020-10-13

📍 Hyderabad · Kolkata · Mumbai · Nashik · New Delhi · Pune

NCT04538664 on ClinicalTrials.gov ↗

Active Phase 3

A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)

Diffuse Large B-Cell Lymphoma
Acerta Pharma BV · started 2020-10-08

📍 Bangalore · Delhi · Kochi · Mumbai · Nashik · Pune

NCT04529772 on ClinicalTrials.gov ↗

No trials match your search.

Browse by location

Mumbai · 22 New Delhi · 18 Bangalore · 16 Pune · 15 Hyderabad · 14 Ahmedabad · 11 Delhi · 9 Jaipur · 9 Chandigarh · 8 Belagavi · 8 Nashik · 8 Nagpur · 7

Browse by condition

Cervical Cancer · 2 Type 2 Diabetes · 2 Diabetes Mellitus, Type 2 · 2 Obesity · 2 Primary Myelofibrosis · 2 Hepatocellular Carcinoma · 2 Carcinoma, Non-Small-Cell Lung · 2 Coronary Artery Disease · 2

Cite this page

Priya Life Science (2026). Clinical Trials in India Tracker. Available at: https://priyalifescience.com/clinical-trials-india/city/nashik (Accessed: 14 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Indian site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.